Results 21 to 30 of about 11,060 (223)

Subcutaneous Implantable Cardioverter-Defibrillator [PDF]

open access: yesCirculation, 2014
For nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead.
Philip M, Chang   +2 more
openaire   +2 more sources

Implantable cardioverter defibrillators in the prevention of sudden cardiac death

open access: yesТерапевтический архив, 2017
The article highlights the role of implantable cardioverter defibrillators (ICDs) in the primary and secondary prevention of sudden cardiac death.
L A Bockeria   +4 more
doaj   +1 more source

Pseudo inappropriate shock: A technical dilemma

open access: yesAnnals of Cardiac Anaesthesia, 2019
With liberal availability of high end cardiac implantable devices in recent era, we frequently encounter patients who are recipients of implantable cardioverter defibrillators (ICDs) in our routine clinical practice.
Pujan J Shah, Aditya Kapoor
doaj   +1 more source

An unusual case of fungal ball on implantable cardioverter defibrillator wire and literature review

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2020
Cardiac Implantable Electronic Device (CIED) includes pacemakers and implantable cardioverter defibrillators (ICD). The device infection is classified into pocket and systemic infection.
Hiba Rauf   +6 more
doaj   +1 more source

Development of ventricular fibrillation after implantation of a biventricular implantable cardioverter defibrillator: what is the mechanism?

open access: yesClinical Case Reports, 2017
Key Clinical Message Syncopal spells in heart failure patient with cardiovascular implantable electronic devices (CIED) require multiple assessments.
Diego Chemello   +3 more
doaj   +1 more source

Coronary Flow in Hypertrophic Obstructive Cardiomyopathy—Immediate Effects of Alcohol Septal Ablation

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic   +12 more
wiley   +1 more source

Comparison Between the Acurate Neo and the Acurate Neo 2 Transcatheter Heart Valve System: Impact of Midframe Under‐Expansion

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) with the Acurate Neo has been linked to a significant incidence of paravalvular leakage (PVL), addressed by the Acurate Neo 2 incorporating an active sealing skirt. Recent findings suggest that midframe under‐expansion is associated with worse outcomes.
Lisa Crusius   +9 more
wiley   +1 more source

Causes of differences in the uptake of cardiac implantation electronic devices in Slovenia in comparison to other countries

open access: yesSlovenian Journal of Public Health, 2018
The purpose of this study is to analyse and present the causes of the differences in crude utilization rate in cardiac implantation electronic devices, specifically pacemakers and automatic implantable cardioverter-defibrillators, across 5 European ...
Prevolnik Rupel Valentina   +2 more
doaj   +1 more source

Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2019
Background/Aims Despite the U.S. Food and Drug Adminstration approving a magnetic resonance imaging (MRI)-conditional pacemaker system in 2011, many physicians remain reluctant to perform MRI scanning in patients with cardiac implantable electronic ...
Donghoon Han   +3 more
doaj   +1 more source

Erosion of an Implantable Cardioverter-Defibrillator

open access: yesJournal of the American College of Cardiology, 2012
![Figure][1] A 51-year-old man with previous myocardial infarction received a single-chamber implantable cardioverter-defibrillator (ICD) in 2002 for syncope and inducible ventricular tachycardia at electrophysiologic testing.
Elmouchi, Darryl, Woelfel, Alan
openaire   +2 more sources

Home - About - Disclaimer - Privacy